Research - News
An oral history of the development of monoclonal antibodies, the foundation of today's most exciting new drug therapies.
The goal is to avoid unnecessary surgery and reduce the number of biopsies of benign nodules and cancers that are unlikely to cause harm.
This is the first demonstration of donor microbes persisting in the recipient following fecal transplant, a finding made possible by a novel method to “fingerprint” individual strains of bacteria.
Birmingham’s culinary scene is making stomachs rumble nationwide, thanks to high praise from Zagat, the James Beard Awards, and just this week, Buzzfeed. Meet some UAB alumni — and a faculty member — cultivating our local flavor, and follow their journeys into the kitchens and restaurants feeding Birmingham’s revitalization.
Michael Birrer, a leading medical oncologist at Harvard University, will take the reins as the new director of the UAB Comprehensive Cancer Center, succeeding the retiring Edward Partridge.
Calvin Kennedy, a nurse at UAB Hospital, is a two-time kidney transplant recipient who has no plans to live an ordinary life.
At a time when medical cannabis and cannabis-based products are gaining traction in the treatment of seizures, one of UAB’s CBD oil investigators serves as a guest editor for a special research journal devoted to cannabinoid research.
Allostery, a fundamental means of regulating enzymes, is crucial for living cells.
Distractions from technology have a detrimental effect on children’s crash risk as pedestrians and drivers.
A biomarker, endothelial mitochondrial function, may be useful for early identification of newborn babies at risk for lung disease and could enable novel therapy approaches.
Funding to UAB for medical research by the National Institutes of Health topped $238 million in 2016, driving innovation and growth.
Successful Phase III trials at UAB contributed to the development of a novel “corrector-potentiator” combination drug therapy for cystic fibrosis patients.
Some of the 18 graduates of the Innovate Birmingham Workforce Program have been offered jobs to begin high-demand information technology careers with local employers like Blue Cross and Blue Shield of Alabama, Brasfield & Gorrie, Regions and UAB.
A UAB symposium on cardiovascular tissue engineering brought together some of the best in the business in this rapidly developing field of translational medicine.
The first target for the UAB spinoff Incysus Ltd. will be glioblastoma. Incysus has just received a European patent for its innovative approach to fighting cancer.
The five-year grant from the NHLBI to the labs of Jennifer and David Pollock also includes a third project at the University of Utah, bringing together three highly successful research entities.
Knowledge from this study and others may help physicians boost healing and prevent heart failure in patients after a heart attack.
A record year for deceased organ donors included more than doubling the number of lungs donated at UAB.
New dye could help better identify ureter, the passage between kidney and bladder, and prevent injury during minimally invasive pelvic surgery for women. 
A multidisciplinary research team at UAB looks to address obesity as it is genetically passed from mother to child.
As lung diseases worsen worldwide, UAB has launched a pre-doctoral training program in pulmonary research that will focus on lung diseases such as asthma, cancer, COPD, cystic fibrosis, pneumonia, lung injury and idiopathic pulmonary fibrosis.
A new clinical trial seeks to determine whether a machine that pumps warm, oxygenated blood in cadaver kidneys can improve quality of the organ prior to transplant.
Transportation engineers in UAB's TRENDLab are studying the effects of ridesharing, autonomous vehicles and other new technologies on roadway congestion. They're also looking at fresh solutions to an age-old highway problem: work zone delays.
The grant will initially fund two fellowship positions for postdoctoral fellows (basic or clinical) wishing to train in the area of heart failure research.
Ongoing multidisciplinary concussion research will be highlighted at an upcoming symposium at UAB: The Concussion Collaborative Science Symposium 2017: Objectively Tackling Concussion through Vision, Science, Radiology and Engineering.
Advances in brain imaging allowing early detection of the plaques implicated in Alzheimer’s disease have pushed prevention strategies in the fight against dementia.
Mitochondrial DNA moving to the nucleus contributes to genomic instability in cancer cells, and a novel Fiber-FISH technique can rapidly map the mitochondrial DNA insertions in nuclear genomes.
A groundbreaking clinical research trial at UAB’s Alabama Vaccine Research Clinic to compare injectable PrEP versus a daily oral regimen for HIV prevention is now recruiting participants.
These microcarriers may offer an entirely different approach to treating solid human tumors of numerous pathologic subtypes by delivering their encapsulated drug cargo to a tumor and protecting against collateral tissue damage.
Just one month after major research findings showed dangerous PFAS present in more than one-third of fast food packaging tested, UAB and Notre Dame created a new technique to track PFASs in the body.